What Has Been the Progress and Growth of the Biopharmaceutical Tubing Market in Recent Years?
The biopharmaceutical tubing market has seen considerable growth due to a variety of factors.
• The biopharmaceutical tubing market has witnessed rapid growth in recent years. It will increase from $4.32 billion in 2024 to $4.82 billion in 2025, growing at a CAGR of 11.7%.
The growth is fueled by a rise in minimally invasive procedures, the expanding elderly population, greater demand for ultra-pure and corrosion-resistant systems, and an increase in demand for diagnostic equipment and drug delivery systems.
What Is The Expected Growth In The Biopharmaceutical Tubing Market Size Evolve over the Forecast Period?
The biopharmaceutical tubing market is expected to maintain its strong growth trajectory in upcoming years.
• The biopharmaceutical tubing market is forecast to see rapid growth, reaching $7.4 billion by 2029, with a CAGR of 11.3%.
Growth drivers include increased biopharmaceutical production, stricter regulations, the rising need for efficient and contamination-free bioprocessing, enhanced safety measures, and growing pharmaceutical research and development. Key trends include advancements in single-use systems, innovations in tubing materials, customized tubing solutions, and improvements in tubing design.
What Main Forces Are Fueling Expansion In The Biopharmaceutical Tubing Market?
The increasing number of personalized medicines is expected to drive the growth of the biopharmaceutical tubing market. Personalized medicine tailors treatments based on an individual's genetic profile and health conditions. As personalized medicine grows due to genetic research, biopharmaceutical tubing plays a key role in providing precise, sterile fluid transfer for customized treatments. For example, in 2022, the Personalized Medicine Coalition reported that 12 new personalized medicines were approved, which accounted for 34% of all newly approved therapies.
What Are The Primary Segments In The Global Biopharmaceutical Tubing Market?
The biopharmaceutical tubing market covered in this report is segmented –
1) By Product: Silicone Tubing, Polyvinyl Chloride (PVC) Tubing, Polyolefin Tubing, Thermoplastic Elastomer Tubing
2) By Manufacturing Process: Extrusion, Vulcanization, Other Manufacturing Processes
3) By Application: Pharmaceutical, Medical Devices, Research And Development, Other Applications
Subsegments:
1) By Silicone Tubing: Medical-Grade Silicone Tubing, Platinum-Cured Silicone Tubing, Peroxide-Cured Silicone Tubing
2) By Polyvinyl Chloride (Pvc) Tubing: Clear Pvc Tubing, Non-Dehp Pvc Tubing, Soft Pvc Tubing
3) By Polyolefin Tubing: Cross-Linked Polyolefin Tubing, Low-Density Polyethylene Tubing, High-DDensity Polyethylene Tubing
4) By Thermoplastic Elastomer Tubing: Medical-Grade Tpe Tubing, Elastomeric Tpe Tubing, Biocompatible Tpe Tubing
Pre-Book The Biopharmaceutical Tubing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Biopharmaceutical Tubing Market?
Companies in the biopharmaceutical tubing market are focusing on developing next-generation solutions such as bioabsorbable tubing to improve performance and sterility. Zeus Company Inc. launched the Absorv XSE-oriented tubing in September 2023, specifically designed for bioresorbable vascular scaffolds. This innovation provides better uniformity, efficiency in laser cutting, and improved performance in medical applications, such as replacing metallic stents.
Who Are the Key Players In The Biopharmaceutical Tubing Market?
Major companies operating in the biopharmaceutical tubing market are:
• Compagnie de Saint-Gobain S.A.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• GE HealthCare Technologies Inc.
• Parker Hannifin Corporation
• DuPont de Nemours Inc.
• Freudenberg Group
• Medline Industries LP
• Avantor Inc.
• Alfa Laval AB
• REHAU Group
• W. L. Gore & Associates Inc.
• Sartorius AG
• Elkem ASA
• Trelleborg AB
• Bio-Rad Laboratories Inc.
• Tekni-Plex Inc.
• Pall Corporation
• Zeus Company Inc.
• Watson-Marlow Ltd.
• Raumedic AG
• Qosina
• Optinova AB
• ESI Ultrapure
What Is The Most Dominant Region In The Biopharmaceutical Tubing Market?
North America was the largest region in the biopharmaceutical tubing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
